)
SyntheticMR (SYNT) investor relations material
SyntheticMR Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Net sales for Q2 2026 increased by 13% year-over-year to 14.0 MSEK, with strong growth in cNeuro and APAC regions.
Operating profit improved to -6.5 MSEK from -8.6 MSEK, and net loss narrowed to -6.1 MSEK from -10.4 MSEK year-over-year.
Cash and cash equivalents rose to 28.3 MSEK at quarter-end, up from 19.4 MSEK last year.
Regulatory approval for CMRI ARIA was obtained in the UK and Switzerland during the quarter.
Leadership changes in the US organization and recruitment of a global CCO to strengthen sales and marketing.
Financial highlights
Q2 net sales: 13,991 TSEK (up 13% year-over-year); H1 net sales: 27,084 TSEK (up 2%).
Q2 operating profit: -6,457 TSEK (margin -46%); H1 operating profit: -12,726 TSEK (margin -47%).
Q2 net profit: -6,089 TSEK; H1 net profit: -12,275 TSEK.
Cash flow from operating activities in Q2: -2,570 TSEK; H1: -6,202 TSEK.
Shareholders’ equity at period end: 125,707 TSEK; equity/assets ratio: 78.2%.
Outlook and guidance
Focus on achieving profitability through increased sales and disciplined cost control.
Capital from the rights issue is being used to strengthen sales, market presence, and strategic partnerships.
Ongoing FDA review for cMRI ARIA in the US; awaiting further feedback.
- Sales fell 8% but losses narrowed; recurring revenue and cash position improved.SYNT
Q1 2026 - Q4 sales up 42% YoY, but full-year loss widened; Combinostics acquisition and new approvals key.SYNT
Q4 2025 - Q3 sales fell 7% with a large impairment, but strategic moves set up a Q4 growth rebound.SYNT
Q3 2025 - Sales grew 4% in Q2, but losses persisted; new CEO and acquisitions drive future growth.SYNT
Q2 2025 - Sales dropped 39% in Q3, but regulatory wins and new hires aim to restore growth.SYNT
Q3 2024 - Q2 sales fell sharply on North America weakness, but growth and new launches support future outlook.SYNT
Q2 2024 - Sales fell 20% in Q1 2025, but recurring revenue and cash flow showed improvement.SYNT
Q1 2025 - Sales fell sharply in 2024, but acquisitions and cost controls set up a 2025 turnaround.SYNT
Q4 2024
Next SyntheticMR earnings date
Next SyntheticMR earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)